Researchers recently found that plasma glial fibrillary acidic protein (GFAP), a blood-based biomarker, can act as an objective indicator of mild traumatic brain injury in older adults.

A recent systematic review by Lucas Tze Peng Tan and colleagues found that recovery after a mild traumatic brain injury (mTBI) is often incomplete and longer-lasting for older adults, with ongoing symptoms frequently missed by standard assessment tools.